Adaptive Biotechnologies
ADPT
ADPT
221 hedge funds and large institutions have $1.74B invested in Adaptive Biotechnologies in 2022 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 88 increasing their positions, 48 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
43% less call options, than puts
Call options by funds: $1.19M | Put options by funds: $2.09M
50% less capital invested
Capital invested by funds: $3.46B → $1.74B (-$1.72B)
Holders
221
Holding in Top 10
2
Calls
$1.19M
Puts
$2.09M
Top Buyers
| 1 | +$27.9M | |
| 2 | +$16.3M | |
| 3 | +$13.4M | |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$13M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$11.7M |
Top Sellers
| 1 | -$58.8M | |
| 2 | -$26.5M | |
| 3 | -$19.6M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$19.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.8M |